https://www.securityweek.com/ransomware-operators-threaten-leak-15tb-supernus-pharmaceuticals-data
Exploit: Ransomware
Supernus Pharmaceuticals: Pharmaceutical Company
Risk to Business: 1.702=Severe Maryland-based Supernus Pharmaceuticals fell prey to a ransomware attack that resulted in a large amount of data being exfiltrated from its networks in mid-November. The Hive ransomware group claimed responsibility for the attack over the Thanksgiving holiday weekend. The group claims to have breached Supernus Pharmaceuticals’ network on November 14 and exfiltrated a total of 1,268,906 files, totaling 1.5 terabytes of data. Supernus Pharmaceuticals says it did not plan to pay a ransom. In a statement, Supernus Pharmaceuticals also disclosed that it did not experience a significant impact on its business, they were quickly able to restore lost data and the company has enacted stronger security measures.
Individual Impact: No consumer PII or financial data loss was disclosed in this breach as of press time.
Customers Impacted: Unknown
How It Could Affect Your Customers’ Business : Companies in the healthcare and pharma sectors have been the favorite targets of ransomware gangs since the start of the global pandemic.
Risk Levels:
1 - 1.5 = Extreme Risk
1.51 - 2.49 = Severe Risk
2.5 - 3 = Moderate Risk
*The risk score is calculated using a formula that considers a wide range of factors related to the assessed breach.
